BofA analyst Joanna Gajuk downgraded Acadia Healthcare (ACHC) to Underperform from Neutral with a price target of $13, down from $21.50.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare downgraded to Market Perform from Outperform at Leerink
- Acadia Healthcare price target lowered to $20 from $33 at Deutsche Bank
- Acadia Healthcare Stock (ACHC) Plunges on Guidance Cut
- Closing Bell Movers: Marvell up 11%, reversing initial earnings selloff
- Acadia Healthcare down 24% at $12.50 after cutting FY25 guidance